Skip to main content
. 2022 Aug 11;37(9):1983–1995. doi: 10.1007/s00384-022-04228-1

Table 3.

Demographics and postoperative complication rate for rectal cancer referred to body mass index

Underweight Normal weight Overweight Obesity Total
Patient population (n/(%)) 13 (2) 208 (38) 209 (39) 111 (21) 541 (100)
Age [year] 62 (42–77) 63 (19–91) 66 (38–86) 65 (34–88) 65 (19–91)
Gender (n/(%))
Male 6 (46) 117 (56) 155 (74) 72 (65) 350 (65)
Female 7 (54) 91 (44) 54 (26) 39 (35) 191 (35)
CCI (points/(%))
0 points 4 (31) 90 (43) 79 (38) 36 (32) 209 (39)
1–2 points 3 (23) 54 (26) 64 (31) 34 (31) 155 (29)
 > 2 points 6 (46) 64 (31) 66 (32) 41 (37) 177 (33)
ASA scorex
2 6 (46) 164 (79) 154 (75) 67 (61) 391 (73)
3 7 (54) 43 (21) 48 (23) 40 (37) 138 (26)
4 - - 4 (2) 2 (2) 6 (1)
5 - - - - -
Localization (n/(%))
Rectosigmoid junction 3 (23) 26 (13) 33 (16) 20 (18) 82 (15)
Upper rectal third 4 (31) 42 (20) 54 (26) 20 (18) 120 (22)
Middel rectal third 3 (23) 89 (43) 86 (41) 39 (35) 217 (40)
Lower rectal third 3 (23) 51 (25) 36 (17) 32 (29) 122 (23)
UICC (n/(%))
Stage 0xx 1 (8) 17 (8) 18 (9) 8 (7) 44 (8)
Stage I - 56 (27) 54 (26) 33 (30) 143 (26)
Stage II 5 (39) 54 (26) 42 (20) 23 (21) 124 (23)
Stage III 2 (15) 41 (20) 53 (25) 28 (25) 124 (23)
Stage IV 5 (39) 39 (19) 42 (20) 19 (17) 105 (19)
Resectiony (n/(%))
Resection with primary anastomoses 11 (85) 160 (77) 172 (83) 85 (76) 427 (80)
Extirpation 2 (15) 47 (23) 34 (17) 26 (24) 109 (20)
Approachyy (n/(%))
Open surgery 13 (100) 172 (83) 184 (88) 95 (86) 464 (87)
Laparoscopic surgery - 34 (16) 22 (11) 15 (14) 71 (13)
Bridge-to-surgery 4 (31) 17 (8) 10 (5) 5 (4) 36 (7)
Emergency surgery - 4 (2) 3 (1) 2 (2) 9 (2)
Simultaneous HIPEC - 2 (1) 1 (< 1) - 3 (< 1)
Wound infection (n/(%))
Yes 2 (15.4) 17 (8.2) 25 (12.0) 20 (18.0) 64 (11.8)
No 11 (84.6) 191 (91.8) 184 (88.0) 91 (82.0) 477 (88.2)
Total 13 (2.4) 208 (38.4) 209 (38.6) 111 (20.5) 541 (100)
Level of wound infection (n/(%))
1 (7.7) 13 (6.3) 19 (9.1) 16 (14.4) 49 (76.6)
II° 1 (7.7) 1 (0.5) 3 (1.4) 1 (0.9) 6 (9.4)
III° - 2 (1.0) 1 (0.5) 1 (0.9) 4 (6.3)
IV° - 1 (0.5) 2 (1.0) 2 (1.8) 5 (7.8)
- - - - -
VI° - - - - -
Total 2 (15.4) 17 (8.2) 25 (12) 20 (18) 541 (100)
Anastomotic leakagez (n/(%))
Yes 1 (9.1) 15 (9.4) 13 (7.6) 8 (9.5) 37 (8.7)
No 10 (90.9) 145 (90.6) 159 (92.4) 76 (90.5) 392 (91.8)
Total 11 (2.6) 160 (37.5) 172 (40.3) 84 (19.7) 427 (100)
Level of anastomotic leakage (n/(%))
- 2 (1.3) 2 (1.2) 1 (1.2) 5 (13.9)
II° 1 (9.1) 4 (2.5) 2 (1.2) 1 (1.2) 8 (22.2)
III° - 2 (1.3) 2 (1.2) - 4 (11.1)
IV° - 7 (4.4) 7 84.1) 5 (6.0) 18 (50)
- - - - -
VI° - - - 1 (1.2) 1 (2.8)
Total 1 (9.1) 15 (9.4) 13 (7.6) 8 (9.5) 36 (100)
In-hospital mortality (n/(%))
sMOF - 1 (0.5) - 1 (0.9) 2 (40)
CV/CP - 2 (1.0) - 1 (0.9) 3 (60)
Total - 3 (1.5) - 2 (1.8) 5 (0.9)

CCI Charlson Comorbidity Index, ASA score American Society of Anesthesiologists, UICC Union for International Cancer Control, RWA resection with primary anastomoses, HIPEC hyperthermic intraperitoneal chemotherapy, sMOF septic multi-organ failure, CV/CP cardiovascular/cardiopulmonary conditional organ failure

xPercentages refer to 535 patients because it was undocumented in 6 patients

xxUICC 0 was awarded for histopathological findings of a pTis and if histopathological examination after neoadjuvant therapy did not reveal any carcinoma

yPercentages refer to 536 patients because the type of resection was undocumented in 5 patients

yyPercentages in terms of surgical approach refer to 535 patients with 6 endoscopically resected carcinomas

zIn 2 rectal carcinoma patients out of a total of 429 patients no classification of preoperative BMI groups could be made